US Patent Issued to Newsoara Biopharmaceutical Technology (Suzhou) on Feb. 24 for "TSLP-binding molecules, IL-33-binding molecules, and bispecific antigen-binding molecules, and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,554, issued on Feb. 24, was assigned to Newsoara Biopharmaceutical Technology (Suzhou) Co. Ltd. (JiangSu, China).

"TSLP-binding molecules, IL-33-binding molecules, and bispecific antigen-binding molecules, and uses thereof" was invented by Wenyi Wang (JiangSu Province, China), Qingqing Yin (JiangSu Province, China) and Yuannian Li (JiangSu Province, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to TSLP-binding molecules, IL-33-binding molecules, and bispecific antigen-binding molecules that simultaneously target TSLP and IL-33. The disclosure also relates to nucleic acid molecules encoding said antigen-binding m...